From EHR to EDC: How AI-assisted intake is reshaping SDV

Source data verification has always served an important purpose in clinical trials. It gives sponsors, CROs, and monitors confidence that the data entered into the eCRF accurately reflects the original source.

But the way SDV is performed has often depended on a highly manual process.

Site teams record data in patient electronic records, lab report, or other source documents. That information is then manually copied into the EDC. Later, a CRA compares the entered values against the source. If something is missing or inconsistent, the issue becomes a query, and the site has to return to the data again.

The principle is sound. The reliance on a manual workflow is where the burden appears.

Manual transcription creates delay, introduces avoidable errors, and adds extra review work for sites, data managers, and CRAs. The integration-free EHR-to-EDC feature in cubeCDMS addresses that friction by bringing source document handling, redaction, auto-fill, remote review, and audit trail visibility closer to the EDC workflow.

The challenge with manual source data flow

SDV is traditionally required because of the way data is captured in the EDC. It sits within a process that is suboptimal, because the data capture workflow is suboptimal.

A value may be recorded in the patient’s Electronic Health Records, copied into the EDC, reviewed by a monitor, queried by a data manager, corrected by the site, and then reviewed again. Each handoff creates another opportunity for delay or discrepancy.

This is especially challenging when source documents are difficult to access remotely, or when the original file contains sensitive information that needs to be hidden before review.

The result is a process where people spend too much time moving and checking data, rather than focusing on the values that need clinical or operational attention.

How integration-free EHR-to-EDC works

The new workflow starts with source document collection inside cubeCDMS.

Users can upload or screen share source documents, such as Electronic Health Records or lab reports, and use AI to extract the required text values and place them into the relevant eCRF fields.

Importantly, the user remains in control.

AI-generated content is clearly identified as something that must be verified. The system does not remove the need for review. Instead, it gives users a faster starting point, with extracted values available inside the eCRF for checking before the page is saved.

This changes the role of the site user from manual transcriber to reviewer.

Audit trails keep the process controlled

Traceability is essential when AI is used in clinical data management.

For eCRF items populated through EHR-to-EDC , cubeCDMS is designed to show whether the value was entered using AI assistance and whether it was changed afterwards. This gives teams a clearer record of how the value entered the system and what happened before it was saved.

That distinction is important in regulated trials.

AI can assist the workflow, but clinical data still needs clear ownership, review, and auditability.

EHR-to-EDC  reduces transcription burden

For site teams, this reduces repetitive data entry.

• For data managers, it reduces avoidable transcription discrepancies.

• For CRAs, it makes the source-to-eCRF relationship easier to review.

The benefit is not simply speed. It is consistency.

When data moves from source document to eCRF through a controlled workflow, there is a clearer path to review, correction, and traceability.

What this means for SDV

EHR-to-EDC does not remove SDV. It reduces the level of SDV required.

When source values are copied into the EDC manually, monitors often need to spend more time checking for transcription errors, raising queries, and waiting for site corrections.

EHR-to-EDC changes this workflow by extracting source data directly into the relevant eCRF fields. The source document, extracted value, and entered data can be reviewed together, making it easier to confirm that the eCRF reflects the original record.

This does not remove the need for SDV or human review. It improves the quality of the data available for review from the start.

With fewer manual transcription steps, teams can reduce avoidable discrepancies, lower query volume, and cut down on site re-work. As a result, SDV becomes faster and more focused, with monitors spending less time checking copied values and more time reviewing the data that genuinely needs attention.

A practical step toward AI-enabled clinical data review

The future of SDV is not about replacing human oversight. It is about removing unnecessary manual work around it.

EHR-to-EDC gives clinical trial teams a practical way to bring source documents, redaction, auto-fill, remote monitoring, and audit trail visibility into one workflow within cubeCDMS.

For sites, it can reduce repetitive entry. For CRAs, it can improve source review. For data managers, it can reduce avoidable discrepancies. For sponsors and CROs, it creates a unified approach to source data intake, EDC review, and SDV.

The result is a cleaner route from source document to verified clinical data.

That is where AI can make a meaningful difference: not by removing control, but by giving study teams better control from the start.

A practical step toward higher-quality clinical data 

The value of EHR-to-EDC is not only that it reduces manual entry. It improves the quality of data at the point it enters the clinical trial workflow.

When source values are extracted into the EDC with user review, teams can reduce transcription errors, lower query volume, and make SDV more focused. This gives monitors and data managers a clearer view of the data that needs attention, while reducing the amount of time spent checking and correcting avoidable discrepancies.

Better data quality earlier in the process also means fewer steps between data capture and data analysis. Critical signals can be identified sooner, review cycles can move faster, and study teams can make decisions with greater confidence.

For sponsors and CROs, this creates a more efficient route from source document to verified clinical data. Fewer manual steps, fewer avoidable errors, and faster review all contribute to lower study costs and more efficient clinical trial delivery.

That is where AI can make a meaningful difference: not by replacing oversight, but by helping clinical trial teams capture better data from the start and move from review to action faster.